Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 2341 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Short Stature, Idiopathic, X-linked | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| LWD; LMD | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Leri-Weill dyschondrosteosis (LWD; MIM 127300) is an autosomal (pseudoautosomal) dominant and Langer mesomelic dysplasia (LMD; MIM 249700) is an autosomal (pseudoautosomal) recessive disorder caused by mutations in the pseudoautosomal genes, SHOX or SHOXY. Causative mutations include gene deletions, point mutations in the coding sequences or large deletions in the non-coding regulatory elements. LWD is characterized by disproportionate short stature, mesomelia, Madelung deformity of the wrist, and tibial bowing. It is usually more severe in females than in males, presumably due to the higher estrogen levels. LMD and LWD are clinically similar, but LMD is more severe. LMD clinical findings include severe limb aplasia, severe hypoplasia of the ulna and fibula, thickened and curved radius and tibia, and hypoplasia of the mandible. In addition, is it estimated that approximately 2-5% of individuals with idiopathic short stature (ISS; MIM 300582) have defects in SHOX or its enhancers. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| SHOX | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Skeletal Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.